| First Author | Ji T | Year | 2016 |
| Journal | Oncotarget | Volume | 7 |
| Issue | 41 | Pages | 66635-66646 |
| PubMed ID | 27556180 | Mgi Jnum | J:309017 |
| Mgi Id | MGI:6754497 | Doi | 10.18632/oncotarget.11365 |
| Citation | Ji T, et al. (2016) Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis. Oncotarget 7(41):66635-66646 |
| abstractText | Interleukin 6 (IL6), tumor necrosis factor alpha (TNFalpha) and TNF receptor-1(TNFR1) have been shown to involve in oval cell proliferation and hepatocellular carcinoma (HCC) development. However, their role in these processes is still unclear. In the present study, by using hepatocytes-specific DDB1 deletion mouse models, we explored the role and mechanism of IL6, TNFalpha and TNFR1 in oval cell proliferation and HCC development in the context of inflammation, which is the common features of HCC pathogenesis in humans. Our results showed that IL6 promotes oval cell proliferation and liver regeneration, while TNFalpha/TNFR1 does not affect this process. Deletion of IL6 accelerates HCC development and increases tumor burden. The number of natural killer(NK) cells is significantly decreased in tumors without IL6, implying that IL6 suppresses HCC by NK cells. In contrast to IL6, TNFR1-mediated signaling pathway promotes HCC development, and deletion of TNFR1 reduced tumor incidence. Increased apoptosis, compensatory proliferation and activation of MAPK/MEK/ERK cascade contribute to the oncogenic function of TNFR1-mediated signaling pathway. Intriguingly, deletion of TNFalpha accelerates tumor development, which shows divergent roles of TNFalpha and TNFR1 in hepatocarcinogenesis. |
